News

Filter

New report shows major increase in pharmaceutical R&D for neglected diseases

16-01-2013

R&D, health system capacity-strengthening efforts, and medicine donations comprise the pharmaceutical…

GlobalPharmaceuticalRare diseasesResearchTropical diseases

Time for government action on investing in neglected diseases R&D

03-12-2012

A five-year review of global neglected disease R&D funding shows that, despite increased investment of…

FinancialPharmaceuticalRare diseasesResearchTropical diseases

Astellas and Tokyo-Tech collaborate on neglected disease research

31-07-2012

The Tokyo Institute of Technology (Tokyo-Tech) and Japanese drug major Astellas Pharma (TYO: 4503) have…

Astellas PharmaPharmaceuticalRare diseasesResearchTropical diseases

Another foray into neglected diseases as GlaxoSmithKline extends partnership with Brazil’s Fiocruz

15-11-2010

UK pharmaceutical giant GlaxoSmithKline (LSE: GSK) and the Brazil-based Oswald Cruz Foundation (Fiocruz)…

GlaxoSmithKlinePharmaceuticalRare diseasesResearchTropical diseases

South Africa first government to use the Pool for Open Innovation to stimulate neglected disease drug R&D

06-05-2010

South Africa's Technology Innovation Agency (TIA) yesterday became the first government agency to join…

Alnylam PharmaceuticalsGlaxoSmithKlinePharmaceuticalRare diseasesResearchRest of the WorldTropical diseases

COMPANY SPOTLIGHT

Menarini

Back to top